Aier Eye Hospital Group Co., Ltd.
300015
株式のランク
#1908
Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic... Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic healthcare services and institutions. Its comprehensive medical offerings encompass specialties such as the diagnosis and treatment of fundus diseases, optometry, refractive correction, glaucoma, corneal conditions, and cataracts. Beyond direct patient care, the company also conducts training courses focused on cataract prevention and management. The group boasts an extensive international footprint, operating approximately 500 ophthalmic facilities across mainland China, with additional presences including 86 in Europe, 1 in the United States, 7 in Hong Kong, and 12 throughout Southeast Asia. Founded in 2007, Aier Eye Hospital Group maintains its headquarters in Changsha, China.
株価
$1.19
時価総額
$11.04B
変化（1日）
-0.38%
変化（1年）
-30.64%
国
CN
取引 Aier Eye Hospital Group Co., Ltd. (300015)
カテゴリー
Healthcare
Aier Eye Hospital Group Co., Ltd.（300015）の収益
Jun 2026 時点の収益 TTM: $3.30B
Aier Eye Hospital Group Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は $3.30B です。2023 年には $2.88B の収益があり、これは 2022 年の $2.34B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Aier Eye Hospital Group Co., Ltd. の収益履歴（2006 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $3.30B | 14.89% |
| 2024 | $2.87B | -0.09% |
| 2023 | $2.88B | 23.20% |
| 2022 | $2.34B | -1.04% |
| 2021 | $2.36B | 29.43% |
| 2020 | $1.82B | 27.10% |
| 2019 | $1.43B | 23.23% |
| 2018 | $1.16B | 27.04% |
| 2017 | $916.49M | 59.06% |
| 2016 | $576.19M | 18.20% |
| 2015 | $487.48M | 25.70% |
| 2014 | $387.80M | 18.51% |
| 2013 | $327.24M | 24.42% |
| 2012 | $263.02M | 26.51% |
| 2011 | $207.90M | 58.66% |
| 2010 | $131.03M | 49.26% |
| 2009 | $87.79M | 36.41% |
| 2008 | $64.35M | 49.22% |
| 2007 | $43.13M | 76.09% |
| 2006 | $24.49M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $78.01B | 2,262.06% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 560.42% |
US
|
|
| $3.89B | 17.93% |
SA
|
|
| $11.08B | 235.63% |
BR
|
